Cortechs.ai and CARPL.ai Partner to Expand Global Access to AI-Powered Imaging Solutions
October 14, 2026, Covington, KY — Cortechs.ai, a global leader in AI-powered neuroimaging solutions, today announced a strategic partnership with
Product updates
Discover what’s new in our AI radiology solutions
Cortechs.ai Partners with ARJ Medical to Advance AI-Driven Neuro and Prostate Imaging in the Middle East
May 27, 2026 Covington, KY – Cortechs.ai, a global leader in AI-powered neuroimaging and quantitative imaging solutions, today announced a strategic
Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies
SAN DIEGO, March 4, 2026 — Cortechs.ai, a global leader in AI-powered neuroimaging solutions, today announced a strategic partnership with Siemens Healthineers to
Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea
Feb. 25, 2026, Covington, KY – Cortechs.ai, a global leader in AI-driven medical imaging analysis, today announced that it has
Product updates
Financial Conflict Of Interest Policy Applicable To NIH Awards
DOWNLOAD FINANCIAL CONFLICT OF INTEREST POLICY APPLICABLE TO NIH AWARDS HERE >>
NeuroQuant® PET: FDA 510(k)-Pending Advancement in Molecular Dementia Imaging
Advancing Quantitative PET Analysis in Dementia Imaging NeuroQuant® PET is FDA 510(k)-Pending for PET quantification and analysis in patients undergoing evaluation
Enhancing Brain Tumor Treatment with RT STRUCT Images: The Promise of Automation
In the realm of neuro-oncology, precision is everything. From diagnosis to treatment planning, clinicians rely on detailed imaging data to
Clinical Performance of NeuroQuant: Transforming Brain MRI Analysis
In clinical practice, automated volumetric MRI analysis has become an essential tool for evaluating neurological disorders with greater accuracy and
The Role of NeuroQuant in Supporting Alzheimer’s Disease Care
World Alzheimer’s Awareness Month is a time to reflect on the challenges of this devastating condition and the innovations that
Reimbursement Considerations for OnQ Prostate and Category III CPT Codes 0648T & 0649T
OnQ Prostate is an FDA‑cleared software solution that uses Restriction Spectrum Imaging (RSI), a patented diffusion MRI technique. RSI focuses on